Pharma Reviews: Healthcare experts to use blockchain for real drug supply

According to Amitabh Kant, CEO, NITI Aayog, “the problem of fake and counterfeit drugs is a major issue, costing the Indian pharma industry billions.
Read more: Healthcare experts to use blockchain for real drug supply

US FDA News: FDA approves a new antibacterial drug to treat a serious lung disease using a novel pathway to spur innovation

The FDA approved the first antibacterial drug under the Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD). LPAD was created by Congress to spur development of drugs targeting serious infections in limited patient populations with unmet need.
Read more: FDA approves a new antibacterial drug to treat a serious lung disease using a novel pathway to spur innovation

US FDA News: FDA approves first treatment for advanced form of the second most common skin cancer

FDA approves Libtayo (cemiplimab-rwlc) for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are not candidates for curative surgery or curative radiation. This is the first FDA approval of a drug specifically for advanced CSCC.
Read more: FDA approves first treatment for advanced form of the second most common skin cancer

Pharma Reviews: NITI Aayog, Oracle sign Statement of Intent to pilot drug supply-chain using blockchain

Mr Kant said "The problem of fake and counterfeit drugs is a major issue, costing the Indian pharma industry billions. At the same time, it's putting ...
Read more: NITI Aayog, Oracle sign Statement of Intent to pilot drug supply-chain using blockchain

US FDA News: FDA authorizes first next generation sequencing-based test to detect very low levels of remaining cancer cells in patients with acute lymphoblastic leukemia or multiple myeloma

FDA authorizes first next generation sequencing-based test to detect very low levels of remaining cancer cells in patients with acute lymphoblastic leukemia or multiple myeloma
Read more: FDA authorizes first next generation sequencing-based test to detect very low levels of remaining cancer cells in patients with acute lymphoblastic leukemia or multiple myeloma

Pharma Reviews: Want to make Uzbekistan part of the Silicon Route instead of the Silk Route: Suresh Prabhu

He mentioned that a Uzbekistan - India Special Pharmaceutical Economic Zone was in the process of being set up in his country. He invited Indian ...
Read more: Want to make Uzbekistan part of the Silicon Route instead of the Silk Route: Suresh Prabhu

Pharma Reviews: NITI Aayog, Oracle, Apollo Hospitals, Strides Pharma team up for real drug supply

“This agreement with Oracle and our partnership with Apollo Hospitals and Strides Pharma, will help ensure all Indian drug manufacturers and ...
Read more: NITI Aayog, Oracle, Apollo Hospitals, Strides Pharma team up for real drug supply

Pharma Reviews: NITI Aayog pushes blockchain and IoT to detect counterfeit drugs in India

“The problem of fake and counterfeit drugs is a major issue, costing the Indian pharma industry billions. At the same time, it's putting patients at higher ...
Read more: NITI Aayog pushes blockchain and IoT to detect counterfeit drugs in India

Pharma Reviews: NITI Aayog partners Oracle to contain drug menace with blockchain technology

Amitabh Kant, CEO, NITI Aayog, said: “The problem of fake and counterfeit drugs is a major issue, costing the Indian pharma industry billions.
Read more: NITI Aayog partners Oracle to contain drug menace with blockchain technology

Pharma Reviews: NITI Aayog, Oracle join forces to fight fake drug distribution in India

Amitabh Kant, CEO, NITI Aayog, said "The problem of fake and counterfeit drugs is a major issue, costing the Indian pharma industry billions.
Read more: NITI Aayog, Oracle join forces to fight fake drug distribution in India

Pharma Reviews: Niti Aayog, Apollo Hospitals partner to use blockchain to curb fake drugs

India's top policy think tank Niti Aayog and Apollo Hospitals have partnered with IT services and solutions provider Oracle and pharma manufacturer ...
Read more: Niti Aayog, Apollo Hospitals partner to use blockchain to curb fake drugs

Pharma Reviews: N Rajaram on how Sanofi plans to be in pink of health in India

In the last five years, barring the one year where we have had an issue with GST as well as demonetisation, the Indian pharma market has grown ...
Read more: N Rajaram on how Sanofi plans to be in pink of health in India

US FDA News: Statement by FDA Commissioner Scott Gottlieb, M.D., on preparations for the upcoming flu season and vaccinations

Statement by FDA Commissioner Scott Gottlieb, M.D., on FDA’s role in preparing for flu season
Read more: Statement by FDA Commissioner Scott Gottlieb, M.D., on preparations for the upcoming flu season and vaccinations

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on modernizing standards of identity and the use of dairy names for plant-based substitutes

FDA issues a request for information to solicit feedback on how consumers are using plant-based substitutes for milk, cheese and other dairy foods.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on modernizing standards of identity and the use of dairy names for plant-based substitutes

Pharma Reviews: Parag Milk Foods lauds higher export subsidy for milk products

It is the largest private dairy FMCG Company with a pan-India presence. .... by the US Food and Drug Administration on one of its manufacturing…
Read more: Parag Milk Foods lauds higher export subsidy for milk products

Pharma Reviews: Cabinet approves India-Uzbekistan MoUs in tourism, trade

Furthermore, the Cabinet approved an MoU between the two countries for the establishment of an Uzbek-Indian Free Pharmaceutical Zone in the ...
Read more: Cabinet approves India-Uzbekistan MoUs in tourism, trade

Pharma Reviews: India and Uzbekistan to increase cooperation to boost pharma sector

The Cabinet Wednesday approved a memorandum of understanding (MoU) to be signed between India and Uzbekistan to increase cooperation in the ...
Read more: India and Uzbekistan to increase cooperation to boost pharma sector

Pharma Reviews: Cabinet nod for India-Uzbekistan MoU on cooperation in pharma sector

The Cabinet also gave it nod to another MoU between India and Uzbekistan for the establishment of the Uzbek-Indian free pharmaceutical zone in the ...
Read more: Cabinet nod for India-Uzbekistan MoU on cooperation in pharma sector

Pharma Reviews: Shocking! This Indian Business Tycoon Earned Rs 300 Crore Per Day Since Last One Year

If we talk about industries, then Pharma sector is the #1 industry for creating wealth: 13.7% of all richest Indians are from Pharma sector. Software and ...
Read more: Shocking! This Indian Business Tycoon Earned Rs 300 Crore Per Day Since Last One Year

Pharma Reviews: Morning Brief: SC's Verdict On Constitutional Validity Of Aadhaar Today; India Added 214 ...

India's pharma industry accounted for 114 billionaires, followed by 66 from software and services and 53 from fast-moving consumer goods.
Read more: Morning Brief: SC's Verdict On Constitutional Validity Of Aadhaar Today; India Added 214 ...

Pharma Reviews: Pharma Sector Mints More Wealthy Indians Than Software, FMCG: Barclays Hurun List

The pharmaceutical industry has minted the most number of wealthy Indians this year, according to Barclays Hurun India Rich List, 2018. The sector ...
Read more: Pharma Sector Mints More Wealthy Indians Than Software, FMCG: Barclays Hurun List

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on new FDA commitment to disclose retailer information for certain food recalls to improve consumer safety

Statement from FDA Commissioner Scott Gottlieb, M.D., on new FDA commitment to disclose retailer information for certain food recalls to improve consumer safety
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on new FDA commitment to disclose retailer information for certain food recalls to improve consumer safety

Pharma Reviews: Make it large—a significant trend in the Indian pharmaceutical industry

The pharmaceutical sector recorded deals worth over $2.1 billion so far in 2018, compared with $1.9 billion across the 12 months of 2017. The spike in ...
Read more: Make it large—a significant trend in the Indian pharmaceutical industry

Pharma Reviews: Indian Syringes, needle maker seek price Cap & inclusion in NLEM

Pharma Industry usually shies from Regulations however in an unusual move the Syringes & Needle manufacturers have written to Chairman of ...
Read more: Indian Syringes, needle maker seek price Cap & inclusion in NLEM

Pharma Reviews: In The Pink Of Health: India's Generic Drug Exporters On A Growth Curve

The fortunes of large Indian generic pharma export companies have visibly changed recently, and the once 'bitter' pill has turned sweet again. And the ...
Read more: In The Pink Of Health: India's Generic Drug Exporters On A Growth Curve

US FDA News: Remarks from Anna Abram as prepared for delivery to the 2018 Intergovermental Meeting on Drug Compounding

Remarks by FDA’s Anna Abram to the 2018 Intergovermental Meeting on Drug Compounding
Read more: Remarks from Anna Abram as prepared for delivery to the 2018 Intergovermental Meeting on Drug Compounding

US FDA News: FDA awards 12 grants to fund new clinical trials to advance the development of medical products for the treatment of rare diseases

FDA has awarded 12 new clinical trial research grants to enhance the development of medical products for patients with rare diseases
Read more: FDA awards 12 grants to fund new clinical trials to advance the development of medical products for the treatment of rare diseases

Pharma Reviews: Soon, uniform inspection norms for pharma units; govt to form advisory body

About 7,000-odd small and large pharma manufacturing units, about 80 per cent of the industry, in India do not follow World Health Organization ...
Read more: Soon, uniform inspection norms for pharma units; govt to form advisory body

Pharma Reviews: Tata Motors lone Indian name among top 100 global R&D spenders

Among the top 10 spenders in India, five are in pharma and three in automotive — industries that have been compelled to invest in R&D due to global ...
Read more: Tata Motors lone Indian name among top 100 global R&D spenders

Pharma Reviews: Closing Bell: Sensex ends 170 points lower in volatile trade, Nifty gives up 11250, HDFC twins top ...

The pharma company said its formulation facility in the southern Indian city of Bengaluru has been issued Form 483 with three observations after U.S. ...
Read more: Closing Bell: Sensex ends 170 points lower in volatile trade, Nifty gives up 11250, HDFC twins top ...

Pharma Reviews: NSF International and IDMA Repeat Successful Bangalore Pharmaceutical Quality Management ...

18, 2018 /PRNewswire/ -- NSF International, a global public health and safety organization, is again partnering with the Indian Drug Manufacturers' ...
Read more: NSF International and IDMA Repeat Successful Bangalore Pharmaceutical Quality Management ...

Pharma Reviews: No coercive steps against drug firms for FDCs already in market, says HC

Justice Vibhu Bakhru granted the relief to some drug manufacturers after ... It had said earlier that no coercive steps be taken against Indian pharma ...
Read more: No coercive steps against drug firms for FDCs already in market, says HC

Pharma Reviews: Pharmaceutical industry urged by DoP to bring innovative drugs without compromising on the quality

Department of Pharmaceutical is taking an Indian delegation to Brussels in collaboration with industry associations like Indian Drug Manufacturers' ...
Read more: Pharmaceutical industry urged by DoP to bring innovative drugs without compromising on the quality

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA’s ongoing efforts to prevent foodborne outbreaks of Cyclospora

he safety of the American food supply is one of the U.S. Food and Drug Administration’s highest priorities. A key part of our work in this space focuses on implementing the principles and measures of the FDA Food Safety Modernization Act (FSMA). The actions directed by FSMA are designed to prevent foodborne illness and food safety problems from happening.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA’s ongoing efforts to prevent foodborne outbreaks of Cyclospora

US FDA News: FDA takes important steps to encourage appropriate and rational prescribing of opioids through final approval of new safety measures governing the use of immediate-release opioid analgesic medications

FDA takes important steps to encourage appropriate and rational prescribing of opioids through final approval of new safety measures governing the use of immediate-release opioid analgesic medications.
Read more: FDA takes important steps to encourage appropriate and rational prescribing of opioids through final approval of new safety measures governing the use of immediate-release opioid analgesic medications

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on launch of ‘The Real Cost’ Youth E-Cigarette Prevention Campaign amid evidence of sharply rising use among kids

Statement from FDA Commissioner Scott Gottlieb, M.D., on launch of ‘The Real Cost’ Youth E-Cigarette Prevention Campaign amid evidence of sharply rising use among kids.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on launch of ‘The Real Cost’ Youth E-Cigarette Prevention Campaign amid evidence of sharply rising use among kids

US FDA News: FDA launches new, comprehensive campaign to warn kids about the dangers of e-cigarette use as part of agency’s Youth Tobacco Prevention Plan, amid evidence of

FDA launched new, comprehensive campaign to warn kids about the dangers of e-cigarette use as part of agency’s Youth Tobacco Prevention Plan, amid evidence of sharply rising use among kids.
Read more: FDA launches new, comprehensive campaign to warn kids about the dangers of e-cigarette use as part of agency’s Youth Tobacco Prevention Plan, amid evidence of

Pharma Reviews: Meet S Srinivasan, the activist-entrepreneur who got 329 irrational combination drugs banned

Srinivasan runs a pharma company and at the same time, raises his voice ... DG Shah, Secretary General of industry body Indian Pharmaceutical ...
Read more: Meet S Srinivasan, the activist-entrepreneur who got 329 irrational combination drugs banned

Pharma Reviews: Pharma weekly wrap: FDC ban and Shivinder Singh's U-turn hog the limelight

The sales of these drugs accounted for 0.8 percent, or around Rs 1,040 crore, of the total sales in Indian Pharmaceutical Market in the year ended ...
Read more: Pharma weekly wrap: FDC ban and Shivinder Singh's U-turn hog the limelight

Pharma Reviews: Large pharma companies can grow faster than industry average

India focus for pharma companies has increased with US challenges sustaining. Scale is important in India and we expect large players to gain ...
Read more: Large pharma companies can grow faster than industry average

Pharma Reviews: Delhi High Court allows pharma major Wockhardt to sell its fixed dose combination drug till Tuesday

The Delhi High Court on Friday allowed Indian pharmaceutical major Wockhardt to sell till Tuesday its anti-inflammatory medicine that is among the ...
Read more: Delhi High Court allows pharma major Wockhardt to sell its fixed dose combination drug till Tuesday

Pharma Reviews: Axis Bank, Sun Pharma among top 5 stocks with strong fundamentals

In textiles and pharma sectors, the value-add by Indian companies is large, hence the apparent benefit of rupee depreciation is large.
Read more: Axis Bank, Sun Pharma among top 5 stocks with strong fundamentals

Pharma Reviews: India Bans 328 Combination Drugs in Setback for Pharma Companies

Health authorities have warned that the increasing use of antibiotic combinations may be contributing to antibiotic resistance, with India of particular ...
Read more: India Bans 328 Combination Drugs in Setback for Pharma Companies

US FDA News: FDA approves device for treatment of acute coronary artery perforations

FDA approves device for treatment of acute coronary artery perforations
Read more: FDA approves device for treatment of acute coronary artery perforations

US FDA News: Statement from Binita Ashar, M.D., of the FDA’s Center for Devices and Radiological Health on agency’s commitment to studying breast implant safety

FDA Statement on agency’s commitment to studying breast implant safety Short Title: FDA Statement on agency’s commitment to studying breast implant safety
Read more: Statement from Binita Ashar, M.D., of the FDA’s Center for Devices and Radiological Health on agency’s commitment to studying breast implant safety

US FDA News: FDA provides update on its ongoing investigation into valsartan products; and reports on the finding of an additional impurity identified in one firm’s already recalled products

FDA update on the ongoing investigation into valsartan impurities, recalls and current findings.
Read more: FDA provides update on its ongoing investigation into valsartan products; and reports on the finding of an additional impurity identified in one firm’s already recalled products

US FDA News: FDA approves new kind of treatment for hairy cell leukemia

FDA approves Lumoxiti (moxetumomab pasudotox-tdfk) for the treatment of adult patients with relapsed or refractory hairy cell leukemia
Read more: FDA approves new kind of treatment for hairy cell leukemia

Pharma Reviews: Banning 328 combination drugs a step towards rectifying 'grave' situation of pharma market: All ...

All India Drug Action Network (AIDAN), a network of NGOs that work to ... The network said when the ban on FDCs was notified, pharma companies in ...
Read more: Banning 328 combination drugs a step towards rectifying 'grave' situation of pharma market: All ...

Pharma Reviews: Centre bans 328 combination drugs in setback for pharma companies

The Indian government has banned 328 combination drugs in a blow to both domestic and foreign pharmaceutical firms, but the ban has been ...
Read more: Centre bans 328 combination drugs in setback for pharma companies

Pharma Reviews: India bans 328 combination drugs in setback for pharma companies

NEW DELHI (Reuters) - The Indian government has banned 328 combination drugs in a blow to both domestic and foreign pharmaceutical firms, but ...
Read more: India bans 328 combination drugs in setback for pharma companies

Pharma Reviews: Voltas' white goods JV with Turkey's Arçelik starts India sales

Voltas' white goods JV with Turkey's Arçelik starts India sales ... According to industry data quoted by Volta, the Indian market for 'major domestic ... an authorized generic version for Daiichi Sankyo's cholesterol drug Welchol in the…
Read more: Voltas' white goods JV with Turkey's Arçelik starts India sales

Pharma Reviews: Centre's FDCs ban: Rs 2000 cr impact expected on Pharma companies

Centre's FDCs ban: Rs 2,000 cr impact expected on Pharma companies ... The total size of the Indian pharmaceutical industry is around Rs 1.18-1.2 ...
Read more: Centre's FDCs ban: Rs 2000 cr impact expected on Pharma companies

Pharma Reviews: How clerk-turned-billionaire Ramprasad Reddy made Aurobindo a giant pharma company

... so — or if it was last Thursday, when Aurobindo Pharma announced the biggest cross-border acquisition by any Indian pharmaceuticals company.
Read more: How clerk-turned-billionaire Ramprasad Reddy made Aurobindo a giant pharma company

Pharma Reviews: Designed to heal

We also have textbooks and stethoscopes that cater to the demands of medical students. Our aim is to enable reputed Indian manufacturers to have ...
Read more: Designed to heal

Pharma Reviews: Pharma industry needs to take pills plus services approach: Ambati Venu, Abbot India

Can you talk about Thyronorm, which is a drug for thyroid in India? The current market size is still very small. Do you expect it to grow massively in the ...
Read more: Pharma industry needs to take pills plus services approach: Ambati Venu, Abbot India

Pharma Reviews: Analytical tools and the AI will play a pivotal role in the pharma industry: Sumit Peer

When we look at the pharmaceutical industry globally the CAGR is 7% and .... It is not that only in India people need pharma and others do not need ...
Read more: Analytical tools and the AI will play a pivotal role in the pharma industry: Sumit Peer

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., and Center for Devices and Radiological Health Director Jeff Shuren, M.D., J.D., on agency efforts to work with tech industry to spur innovation in digital health

FDA Statement on agency efforts to work with tech industry to spur innovation in digital health
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., and Center for Devices and Radiological Health Director Jeff Shuren, M.D., J.D., on agency efforts to work with tech industry to spur innovation in digital health

US FDA News: FDA awards five grants to advance the development of pediatric medical devices

FDA has awarded grants to five Pediatric Device Consortia that will provide advice to innovators of children's medical devices
Read more: FDA awards five grants to advance the development of pediatric medical devices

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to address epidemic of youth e-cigarette use

Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to address epidemic of youth e-cigarette use
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to address epidemic of youth e-cigarette use

US FDA News: FDA takes new steps to address epidemic of youth e-cigarette use, including a historic action against more than 1,300 retailers and 5 major manufacturers for their roles perpetuating youth access

FDA takes new steps to address epidemic of youth e-cigarette use, including a historic action against more than 1,300 retailers and 5 major manufacturers for their roles perpetuating youth access
Read more: FDA takes new steps to address epidemic of youth e-cigarette use, including a historic action against more than 1,300 retailers and 5 major manufacturers for their roles perpetuating youth access

Pharma Reviews: Indian pharma market grew 8.7% in August on slower offtake of anti-infectives

The Indian pharmaceutical market (IPM) grew at 8.7 percent in August, much slower than in July due to lacklustre sales of anti-infective drugs, ...
Read more: Indian pharma market grew 8.7% in August on slower offtake of anti-infectives

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on new warning letters FDA is issuing to companies marketing kratom with unproven medical claims; and the agency’s ongoing concerns about kratom

Statement from FDA Commissioner Scott Gottlieb, M.D., on new warning letters FDA is issuing to companies marketing kratom with unproven medical claims; and the agency’s ongoing concerns about kratom
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on new warning letters FDA is issuing to companies marketing kratom with unproven medical claims; and the agency’s ongoing concerns about kratom

Pharma Reviews: Stock Market LIVE: Sensex gains 90 points, Nifty above 11450, Sun Pharma top gainers

Real estate firm Kalpataru Ltd has entered into a joint development agreement with pipe manufacturer Indian Hume Pipe Co. Ltd, to develop a 15-acre ...
Read more: Stock Market LIVE: Sensex gains 90 points, Nifty above 11450, Sun Pharma top gainers

US FDA News: USDA and FDA announce joint public meeting on use of animal cell culture technology to develop products derived from livestock and poultry

WASHINGTON, Sept. 10, 2018 – U.S. Secretary of Agriculture Sonny Perdue, DVM and U.S. Food and Drug Administration Commissioner Scott Gottlieb, M.D. today announced a joint public meeting to be held on Oct. 23-24, 2018 to discuss the use of cell culture technology to develop products derived from livestock and poultry.
Read more: USDA and FDA announce joint public meeting on use of animal cell culture technology to develop products derived from livestock and poultry

Pharma Reviews: Johnson and Johnson faulty hip implants case: Why India is an easy victim for such malpractices

The market regulator Central Drugs Standard Control Organisation ... In fact, industry reports reveal the Indian medical device market is currently ...
Read more: Johnson and Johnson faulty hip implants case: Why India is an easy victim for such malpractices

Pharma Reviews: Journey towards correction begins: It's time for selective profit taking

Indian pharmaceutical industry is the largest exporter of drugs to the US and this deal is a red signal for the Indian pharma companies, which are ...
Read more: Journey towards correction begins: It's time for selective profit taking

Pharma Reviews: Reconsider move to ban 15 fixed-drug combos, apex court tells Health Ministry

The 15 FDCs include those of big brands like Abbott Healthcare's Phensydyl, Paras Pharmaceutical's D - Cold Tablet, Alkem's Sumo,Franco-Indian ...
Read more: Reconsider move to ban 15 fixed-drug combos, apex court tells Health Ministry

US FDA News: FDA approves new dosage strength of buprenorphine and naloxone sublingual film as maintenance treatment for opioid dependence

FDA approved Cassipa (buprenorphine and naloxone) sublingual film (applied under the tongue) for the maintenance treatment of opioid dependence.
Read more: FDA approves new dosage strength of buprenorphine and naloxone sublingual film as maintenance treatment for opioid dependence

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to help ensure the quality of and preserve access to compounded drugs by pursuing closer collaboration with states

FDA announces revised draft memorandum of understanding between FDA and the states to help ensure the quality of and preserve access to compounded drugs
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to help ensure the quality of and preserve access to compounded drugs by pursuing closer collaboration with states

Pharma Reviews: 'Hyderabad key for pharma industry'

Indian pharma is tapping the export segment. About 50 per cent of the pharma production goes for exports and the remaining is for domestic ...
Read more: 'Hyderabad key for pharma industry'

Pharma Reviews: Pharma expo begin at Hitex

The event is being organised by Indian Pharma Machinery Manufacturers Association and Indian Analytical Industry Association in collaboration with ...
Read more: Pharma expo begin at Hitex

Pharma Reviews: Pharma sector's outlook is positive for the next 3-5 years: Sailesh Raj Bhan of Reliance MF

Pharma experts believe that Indian pharma industry is estimated to touch $55 billion by FY20. How do you see the category growing in the coming ...
Read more: Pharma sector's outlook is positive for the next 3-5 years: Sailesh Raj Bhan of Reliance MF

Pharma Reviews: RBL Bank, Prabhat Dairy among top 10 stocks that could return 15-60% over 1-year

The market is continuing to correct and consolidate after hitting record highs .... which feature amongst the top 100 brands in Indian pharma industry.
Read more: RBL Bank, Prabhat Dairy among top 10 stocks that could return 15-60% over 1-year

Pharma Reviews: GSK Pharma in search of buyer for non-core brands

MUMBAI: British drug maker GSK Pharma's India arm is looking to sell some of its non-core brands as the company looks to consolidate its position in ...
Read more: GSK Pharma in search of buyer for non-core brands

Pharma Reviews: Ascent Health: the startup that went backward to move forward

According to industry estimates, there are 850,000 to 900,000 pharmaceutical retailers in India. Supplying to them is an enormous network of 80,000 ...
Read more: Ascent Health: the startup that went backward to move forward

Pharma Reviews: Coca-Cola, Zydus Cadila battle for Kraft Heinz India brands

The Coca-Cola Co., the world's largest beverage company, and the Zydus Cadila Group have emerged as the two strongest contenders for the ...
Read more: Coca-Cola, Zydus Cadila battle for Kraft Heinz India brands

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on an updated approach for including added sugar information on the Nutrition Facts labels of pure maple syrup and honey

Proposed rule revises front of package calorie labeling requirements to provide more flexibility to industry
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on an updated approach for including added sugar information on the Nutrition Facts labels of pure maple syrup and honey

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s global efforts to help assure product quality and transparency at foreign drug manufacturing facilities

FDA is publishing its internal policy for how manufacturing facilities are prioritized and scheduled for surveillance inspections in an effort to ensure the quality and safety of globally produced products.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s global efforts to help assure product quality and transparency at foreign drug manufacturing facilities

Pharma Reviews: Pharma outlook stable despite intensifying profitability headwinds

Ind-Ra expects the Indian pharmaceutical sector's operating profitability to remain subdued in FY19 on account of the twin headwinds of input price ...
Read more: Pharma outlook stable despite intensifying profitability headwinds

Pharma Reviews: Pharma CIO show a big success

Indian pharmaceutical companies have already created excellence in the global market. However, as the industry has embarked on its journey ...
Read more: Pharma CIO show a big success

Pharma Reviews: Automobile, pharma firms big beneficiaries of export incentive scheme

The US had alleged that thousands of Indian companies are receiving benefits totalling over USD 7 billion annually under various export promotion ...
Read more: Automobile, pharma firms big beneficiaries of export incentive scheme

Pharma Reviews: MARKET WRAP: Sensex dips 333 pts; PMI data, proposed FPI norms spook Street

READ MORE India manufacturing growth eases in August on softer ... for a one-year period The rally in pharmaceutical stocks owing to the rupee ...
Read more: MARKET WRAP: Sensex dips 333 pts; PMI data, proposed FPI norms spook Street

Pharma Reviews: Price control, ad-hoc regulatory changes may hamper pharma sector growth: Pfizer

The Indian pharma market stood at Rs 121,833 crore at the end of financial year 2018, growing at 6.3 per cent over the last 12 months period.
Read more: Price control, ad-hoc regulatory changes may hamper pharma sector growth: Pfizer

Pharma Reviews: Rupee hits 71 mark: Read how it may impact you

The external borrowing costs for Indian firms will only move up in the ... Information technology and pharma companies benefit from a weak rupee ...
Read more: Rupee hits 71 mark: Read how it may impact you

Pharma Reviews: Gland Pharma seeks pitches from investment bankers to go public

The company had to struggle with the Indian government to receive regulatory approvals as the government feared monopoly of Chinese drug makers ...
Read more: Gland Pharma seeks pitches from investment bankers to go public